NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy.

Autor: Rothan, Hussin A.1, Amini, Elham2, Faraj, Fadihl L.3, Golpich, Mojtaba2, Teoh, Teow Chong4, Gholami, Khadijeh5, Yusof, Rohana1
Zdroj: Scientific Reports. 3/31/2017, p45540. 1p.
Databáze: Academic Search Ultimate